Summary
We previously demonstrated that nipple aspirate fluid (NAF) can be obtained from virtually all non-Asian women between the ages of 30 and 72. The focus of this report is to (1) determine the association of candidate markers of breast cancer risk in NAF obtained from fresh mastectomy specimens with residual breast carcinoma, and (2) evaluate the association of the markers with breast tumour progression. Nipple aspiration was performed on 97 specimens. Cytology, DNA index (including % hypertetraploid cells), cell cycle parameters (S phase fraction, % cells in G2/M), prostate-specific antigen (PSA), epidermal growth factor (EGF), testosterone, carcinoembryonic antigen (CEA) and prostaglandin D synthase (PGDS) were evaluated in NAF for their association with (1) residual ductal carcinoma in situ (DCIS) or invasive cancer, and (2) pathologic tumour size. NAF was obtained from 99% (96/97) of specimens. Atypical and malignant NAF cytology were significantly associated with residual DCIS or invasive cancer (P = 0.001) and with larger tumours (P = 0.004). One hundred per cent and 88% of subjects with malignant and atypical NAF cytology, respectively, had residual carcinoma. The percentage of cells in G2/M and DNA index were associated both with risk of residual carcinoma (P = 0.01 for each) and larger tumour size (DNA index, P = 0.03; G2/M, P = 0.05), although neither biomarker improved the ability of NAF cytology, to predict residual breast cancer. Higher DNA index was associated with atypical cytology (P = 0.0001). In summary, atypical and malignant NAF cytology are associated with larger tumour size, and are highly predictive of residual carcinoma after needle or excisional biopsy of the breast.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Agresti, A (1990). Categorical Data Analysis. Wiley & Sons: New York 59–64, and 321–324.
Anscher, MS, Jones, P, Prosnitz, LR, Blackstock, W, Hebert, M, Reddick, R, Tucker, A, Dodge, R, Leight, G Jr & Iglehart, JD (1993). Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218: 22–28.
Dressler, LG, Seamer, LC, Owens, MA, Clark, GM & McGuire, WL (1988). DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420–427.
Earp, HS, Dawson, TL, Li, X & Yu, H (1995). Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35: 115–132.
Ellison, DA, Maygarden, SJ & Novotny, DB (1995). Quantitative DNA analysis of fresh solid tumors by flow and image cytometric methods: a comparison using the Roche Pathology Workstation image analyzer. Modern Pathol 8: 275–281.
Falk, RT, Dorgan, JF, Kahle, L, Potischman, N & Longcope, C (1996). Assay reproducibility of hormone measurements in postmenopausal women. Cancer Epidemiol Biomarkers Prev 6: 429–432.
Frazier, TG, Wong, RWY & Rose, D (1989). Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg 124: 37–38.
Gwin, JL, Eisenberg, BL, Hoffman, JP, Ottery, FD, Boraas, M & Solin, LJ (1993). Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg 218: 729–734.
Haagensen, C, Lane, N, Lattes, R & Bodian, C (1978). Lobular neoplasia of the breast. Cancer 421: 737–769.
Hallahan, DE, Michel, AG, Halpern, HJ, Awan, AM, Desser, R, Bitran, J, Recant, W, Wyman, B, Spelbring, DR & Weichselbaum, RR (1989). Breast conserving surgery and definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 17: 1211–1216.
Harris, JR, Morrow, M & Bonnadonna, G (1993). Cancer of the breast. InCancer: Principles and Practice of Oncology, 4th ed, DeVita VT Jr, Hellman S, Rosenberg S A J.B. Lippincott: Philadelphia 1264–332.
Keynes, G (1923). Chronic mastitis. Br J Surg 11: 89–121.
King, EB, Barrett, D, King, MC & Petrakis, NL (1975). Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol 64: 728–738.
King, EB, Chew, KL, Petrakis, NL & Ernster, VL (1983). Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 71: 1115–1121.
Lagios, MD (1992). Pathologic features related to local recurrence following lumpectomy and irradiation. Semin Surg Oncol 8: 122–128.
Lai, LC, Ghilchik, MW, Shaikh, NA, Reed, MJ & James, VHT (1989). Relationship of epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid. Br J Cancer 60: 320–323.
Leis, HP (1991). Prognostic parameters for breast carcinoma. In The Breast, Bland KI, Copeland EM WB Saunders: Philadelphia 331–351.
Melegos, DN, Diamandis, EP, Oda, H, Urade, Y & Hayaishi, O (1991). Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids. Clin Chem 42: 1984–1991.
McCormick, B, Kinne, D, Petrek, J, Osborne, M, Cox, L, Shank, B, Hellman, S, Yahalom, J & Rosen, PP (1987). Limited resection for breast cancer: a study of inked specimen margins before radiotherapy. Int J Radiat Oncol Biol Phys 13: 1667–1671.
Olivotto, IA, Rose, MA, Osteen, RT, Love, S, Cady, B, Silver, B, Recht, A & Harris, JR (1989). Late cosmetic outcome after conservation surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 17: 747–753.
Petrakis, NL, Mason, L, Lee, R, Sugimoto, B, Pawson, S & Catchpool, F (1975). Association of race, age, menopausal status, and cerumen type with brest fluid secretion in nonlactating women, as determined by nipple aspiration. J Natl Cancer Inst 54: 829–834.
Sauer, R, Schauer, A, Rauschecker, HF, Schumacher, M, Gatzemeier, W, Schmoor, C, Dunst, J, Seegenschmiedt, MH & Marx, D (1992). Therapy of small breast cancer: a prospective study on 1036 patients with special emphasis on prognostic factors. Int J Radiat Oncol Biol Phys 23: 907–914.
Sauter, ER, Daly, M, Linahan, K, Ehya, H, Engstrom, PF, Bonney, G, Ross, EA, Yu, H & Dlamandis, E (1996). Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidem Biomarkers Prev 5: 967–970.
Sauter, ER, Ross, E, Daly, M, Klein-Szanto, A, Engstrom, PF, Sorling, A, Malick, J & Ehya, H (1997). Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76: 494–501.
Schnitt, SJ, Connolly, JL, Khettry, U, Mazoujian, G, Brenner, M, Silver, B, Recht, A, Beadle, G & Harris, JR (1987). Pathologic findings on reexcision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 59: 675–681.
Schwartz, GF, Rosenberg, AL, Danoff, BF, Mansfield, CM & Feig, SA (1984). Lumpectomy and level I axillary dissection prior to irradiation for “operable” breast cancer. Ann Surg 200: 554–560.
Stotter, AT, McNeese, MD, Ames, FC, Oswald, MJ & Ellerbroek, NA (1989). Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64: 2217–2225.
Thompson, DMP, Krupey, J, Freeman, SO & Gold, P (1969). The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 64: 161–167.
Veronesi, U, Volterrani, F, Luini, A, Saccozzi, R, DelVecchio, M, Zucali, R, Galimberti, V, Rasponi, A, Di Re, E & Squicciarini, P (1990). Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26: 671–673.
Wrensch, MR, Petrakis, NL, King, EB, Miike, R, Mason, L, Chew, KL, Lee, MM, Ernster, VL, Hilton, JF & Schweitzer, R (1992). Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidem 135: 130–141.
Yeatman, TJ & Bland, Kl Staging of breast cancer. In: The Breast, Bland KI, Copeland EM (eds), pp. 313–330. WB Saunders: Philadelphia
Author information
Authors and Affiliations
Additional information
Presented in part at the American Association for Cancer Research, New Orleans, LA in March 1998
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sauter, E., Ehya, H., Babb, J. et al. Biologic markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer 81, 1222–1227 (1999). https://doi.org/10.1038/sj.bjc.6690832
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690832
Keywords
This article is cited by
-
Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer
Clinical Proteomics (2018)
-
Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women
Biomarker Research (2013)
-
Does mammary ductoscopy have a role in clinical practice?
International Seminars in Surgical Oncology (2006)